Table 3 Baseline SUVmean in healthy tissue and PET2 response.

From: Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients

Tissue of interest

PET0 (SUVmean)

OR (95% CI)

p-value

CMR (PET2−) N = 150 Median (IQR)

Non-CMR (PET2 +) N = 48 Median (IQR)

BM

2.3 (1.9–2.8)

2.6 (2.2–3.1)

1.64 (1.06–2.51)

0.025*

Spleen

1.9 (1.7–2.3)

1.8 (1.7–2.3)

0.86 (0.47–1.55)

0.61

Liver

1.8 (1.5–2.1)

1.8 (1.6–2.1)

1.07 (0.47–2.46)

0.87

MBP

1.4 (1.2–1.6)

1.4 (1.2–1.6)

1.31 (0.44–3.87)

0.63

  1. Significant values are in bold.
  2. *Results are very similar when adjusted for age, stage, baseline haemoglobin, B-symptoms, and bulky disease (1.72, 95% CI 1.07–2.76; p = 0.025). SUVmean mean standardised uptake value, CMR complete metabolic response, N number, BM bone marrow, MBP mediastinal blood pool, OR odds ratio, CI confidence interval.
Back to article page